Abstract
Subunits of a proline-rich coccidioidal antigen (Ag2/PRA) of Coccidioides immitis were analyzed by comparison as vaccines in mice. The optimal dose of plasmid vaccine encoding full-length Ag2/PRA was determined to be between 10 and 100 microg. Mice vaccinated with plasmids encoding amino acids (aa) 1 to 106 were as protective as full-length Ag2/PRA (aa 1 to 194). The subunit from aa 27 to 106 was significantly but less protective. Plasmids encoding aa 90 to 151 or aa 90 to 194 were not protective. Analogous results were obtained with recombinant vaccines of the same amino acid sequences. In addition, mixtures of aa 90 to 194 with either aa 1 to 106 or aa 27 to 106 did not enhance protection compared to the active single-recombinant subunits alone. Humoral response of total immunoglobulin G (IgG) and subclasses IgG1 and IgG2a were detectable in subunit vaccinations but at significantly (100-fold) lower concentrations than after vaccination with plasmids encoding full-length Ag2/PRA. Since virtually all protection by vaccination with full-length Ag2/PRA can be accounted for in the first half of the protein (aa 1 to 106), this subunit could make a multicomponent vaccine more feasible by reducing the quantity of protein per dose and the possibility of an untoward reactions to a foreign protein.
MeSH Terms
Amino Acid Sequence
Animals
Antibodies, Fungal/biosynthesis
Antigens, Fungal/genetics,immunology
Coccidioides/genetics,immunology
Coccidioidomycosis/prevention & control
DNA, Fungal/immunology
Disease Models, Animal
Female
Fungal Proteins
Fungal Vaccines/genetics,immunology
Glycoproteins/genetics,immunology
Mice
Mice, Inbred BALB C
Molecular Sequence Data
Peptides/genetics,immunology
Recombinant Fusion Proteins/genetics,immunology
Vaccines, DNA/immunology
Chemicals
Antibodies, Fungal
Antigens, Fungal
DNA, Fungal
Fungal Proteins
Fungal Vaccines
Glycoproteins
Peptides
Recombinant Fusion Proteins
Vaccines, DNA
antigen 2, Coccidioides
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Peng Tao
Valley Fever Center for Excellence and Research Program, Southern Arizona Veterans Affairs Health Care System, Tucson, Arizona 85723, USA.
Shubitz Lisa
Simons Julie
Perrill Robert
Orsborn Kris I
Galgiani John N
References (24)
24 references, click to expand
-
Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis.
Infect Immun. 1999 Nov;67(11):5848-53
PMID: 10531239
-
IMMUNIZATION OF MICE TO COCCIDIOIDES IMMITIS: DOSE, REGIMEN AND SPHERULATION STAGE OF KILLED SPHERULE VACCINES.
J Immunol. 1965 Jan;94:132-42
PMID: 14253511
-
Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America.
Clin Infect Dis. 2000 Apr;30(4):658-61
PMID: 10770727
-
Identification and characterization of TUP1-regulated genes in Candida albicans.
Genetics. 2000 Sep;156(1):31-44
PMID: 10978273
-
Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities.
Fungal Genet Biol. 2001 Feb;32(1):1-9
PMID: 11277621
-
Coccidioides immitis as a Select Agent of bioterrorism.
J Appl Microbiol. 2001 Oct;91(4):602-5
PMID: 11576294
-
Coccidioidomycosis in workers at an archeologic site--Dinosaur National Monument, Utah, June-July 2001.
MMWR Morb Mortal Wkly Rep. 2001 Nov 16;50(45):1005-8
PMID: 11724157
-
Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA.
Infect Immun. 2002 Jun;70(6):3287-9
PMID: 12011027
-
An epidemic of coccidioidomycosis among archeology students in northern California.
N Engl J Med. 1972 Mar 9;286(10):507-12
PMID: 5059262
-
Coccidioidomycosis at a university health service.
Am Rev Respir Dis. 1985 Jan;131(1):100-2
PMID: 3966695
-
Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.
Am Rev Respir Dis. 1993 Sep;148(3):656-60
PMID: 8368636
-
MHC ligands and peptide motifs: first listing.
Immunogenetics. 1995;41(4):178-228
PMID: 7890324
-
Coccidioidomycosis.
N Engl J Med. 1995 Apr 20;332(16):1077-82
PMID: 7898527
-
Molecular cloning and characterization of Coccidioides immitis antigen 2 cDNA.
Infect Immun. 1996 Jul;64(7):2695-9
PMID: 8698497
-
Coccidioides immitis antigen 2: analysis of gene and protein.
Gene. 1996 Nov 28;181(1-2):121-5
PMID: 8973319
-
A coccidioidomycosis outbreak following the Northridge, Calif, earthquake.
JAMA. 1997 Mar 19;277(11):904-8
PMID: 9062329
-
Identification of a Coccidioides immitis antigen 2 domain that expresses B-cell-reactive epitopes.
Infect Immun. 1997 Aug;65(8):3376-80
PMID: 9234800
-
In silicio identification of glycosyl-phosphatidylinositol-anchored plasma-membrane and cell wall proteins of Saccharomyces cerevisiae.
Yeast. 1997 Dec;13(15):1477-89
PMID: 9434352
-
Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice.
Infect Immun. 1998 Aug;66(8):3519-22
PMID: 9673228
-
Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.
Infect Immun. 1999 Feb;67(2):630-5
PMID: 9916069
-
Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.
Infect Immun. 1999 Jun;67(6):2935-40
PMID: 10338502
-
Magnaporthe grisea pth11p is a novel plasma membrane protein that mediates appressorium differentiation in response to inductive substrate cues.
Plant Cell. 1999 Oct;11(10):2013-30
PMID: 10521529
-
Immunogenicity of spherule-endospore vaccines of Coccidioides immitis for mice.
J Immunol. 1961 Aug;87:218-27
PMID: 13761478
-
Outbreak of coccidioidomycosis in Washington state residents returning from Mexico.
Clin Infect Dis. 2000 Jan;30(1):61-4
PMID: 10619734